{"id":"trizivir","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL129","moleculeType":"Small molecule","molecularWeight":"267.24"},"aliases":["abacavir","abacavir sulfate","lamivudine","zidovudine","TZV"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"3354e50f-4dc5-413f-b5ae-87353ab8913d","title":"TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:14:47.743Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00084149","phase":"PHASE2","title":"Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-02","conditions":"HIV Infections","enrollment":54},{"nctId":"NCT00270296","phase":"PHASE2","title":"Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-06","conditions":"HIV Infections","enrollment":730},{"nctId":"NCT01352715","phase":"PHASE3","title":"Study of Options for Second-Line Effective Combination Therapy (SELECT)","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2012-03-13","conditions":"HIV-1 Infection","enrollment":515},{"nctId":"NCT00449436","phase":"PHASE4","title":"Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01-10","conditions":"HIV Infections","enrollment":152},{"nctId":"NCT01077557","phase":"","title":"Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2006-11","conditions":"Fracture, Infection, Human Immunodeficiency Virus","enrollment":1},{"nctId":"NCT00082394","phase":"PHASE4","title":"A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-04-26","conditions":"Infection, Human Immunodeficiency Virus I, HIV Infection","enrollment":""},{"nctId":"NCT00038506","phase":"PHASE4","title":"Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2002-03","conditions":"HIV Infection","enrollment":100},{"nctId":"NCT00979706","phase":"PHASE4","title":"Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).","status":"COMPLETED","sponsor":"Juan A. Arnaiz","startDate":"2005-03","conditions":"HIV","enrollment":22},{"nctId":"NCT00834457","phase":"PHASE2, PHASE3","title":"A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe","status":"COMPLETED","sponsor":"Parirenyatwa Hospital","startDate":"2007-06","conditions":"AIDS-related Kaposi's Sarcoma","enrollment":49},{"nctId":"NCT02028676","phase":"PHASE4","title":"Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2007-03","conditions":"Human Immunodeficiency Virus","enrollment":1206},{"nctId":"NCT00624195","phase":"PHASE2, PHASE3","title":"Clinical Trial of CNS-targeted HAART (CIT2)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2007-03","conditions":"HIV Infections","enrollment":59},{"nctId":"NCT00865475","phase":"PHASE4","title":"Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC","status":"COMPLETED","sponsor":"Fundacion SEIMC-GESIDA","startDate":"2008-12","conditions":"HIV Infection, HIV Infections","enrollment":38},{"nctId":"NCT00960622","phase":"PHASE4","title":"Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2006-08","conditions":"HIV","enrollment":17},{"nctId":"NCT00043888","phase":"PHASE3","title":"Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-01","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT01054638","phase":"","title":"HIV Treatment and CVD Events","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2009-03","conditions":"HIV Infection, Cardiovascular Disease, Infection, Human Immunodeficiency Virus","enrollment":""},{"nctId":"NCT00405925","phase":"PHASE3","title":"FREE Study: Efficacy and Toxicity of Trizivir","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2003-03","conditions":"HIV Infections","enrollment":207},{"nctId":"NCT00851630","phase":"PHASE4","title":"Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)","status":"COMPLETED","sponsor":"Duke University","startDate":"2004-06","conditions":"HIV, Tuberculosis","enrollment":70},{"nctId":"NCT00765271","phase":"PHASE1","title":"Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects","status":"COMPLETED","sponsor":"St Stephens Aids Trust","startDate":"2008-05","conditions":"HIV","enrollment":29},{"nctId":"NCT00356616","phase":"PHASE4","title":"Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients","status":"TERMINATED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2005-09","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT00127972","phase":"PHASE4","title":"2NN & CHARM Long-Term Follow-up Study","status":"COMPLETED","sponsor":"International Antiviral Therapy Evaluation Center","startDate":"2004-02","conditions":"HIV Infections","enrollment":763},{"nctId":"NCT00011895","phase":"PHASE4","title":"Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs","status":"UNKNOWN","sponsor":"GlaxoSmithKline","startDate":"2001-02","conditions":"HIV Infections","enrollment":400},{"nctId":"NCT00004981","phase":"PHASE3","title":"Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)","status":"UNKNOWN","sponsor":"Glaxo Wellcome","startDate":"","conditions":"HIV Infections","enrollment":230}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":47,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Trizivir","genericName":"Trizivir","companyName":"St. Luke's-Roosevelt Hospital Center","companyId":"st-luke-s-roosevelt-hospital-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":7,"withResults":3},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}